Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.
View Top Employees from AbingworthWebsite | http://www.abingworth.com |
Revenue | $50 million |
Employees | 43 (35 on RocketReach) |
Founded | 1973 |
Phone | +44 20 7534 1500 |
Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
Industry | Venture Capital and Private Equity Principals, Investment Banking, Biotechnology, Investing in life sciences, Finance, Science and Engineering, Health Diagnostics, Health Care, Medical, Medical Device |
Web Rank | 3 Million |
Keywords | Stanmore Prosthesys, Abingworth, Dr Peter Goodfellow Abingworth Llp, Barcelona Champion, Abingworth Bioventures |
Competitors | 5AM Ventures, ATP (Apple Tree Partners), Alta Partners, Pappas Capital, SV Health Investors |
SIC | SIC Code 679 Companies, SIC Code 67 Companies |
NAICS | NAICS Code 52 Companies, NAICS Code 5239 Companies, NAICS Code 523 Companies |
Looking for a particular Abingworth employee's phone or email?
The Abingworth annual revenue was $50 million in 2024.
Neil Cooper is the CFO of Abingworth.
35 people are employed at Abingworth.
The NAICS codes for Abingworth are [52, 5239, 523].
The SIC codes for Abingworth are [679, 67].